The week that just rolled by was a mixed bag in terms of regulatory and clinical trial results - with some stocks vaulting to new highs on positive news and some cratering in response to the negative news.
from RTT - Biotech https://ift.tt/2IByqU8
via IFTTT
No comments:
Post a Comment